Sable · Question
What is the difference between KPV and SLU-PP-332?
KPV is the C-terminal tripeptide of alpha-melanocyte-stimulating hormone, studied in inflammation-signalling research in cell and rodent models (peptide, MW about 342.43 g/mol).
Research use only. Not for human consumption. No health claims.
Last verified 2026-10-10
What is the difference between KPV and SLU-PP-332?
KPV is the C-terminal tripeptide of alpha-melanocyte-stimulating hormone, studied in inflammation-signalling research in cell and rodent models (peptide, MW about 342.43 g/mol).
Which is heavier, KPV or SLU-PP-332?
KPV has a molecular weight of about 342.43 g/mol and SLU-PP-332 about 290.3 g/mol (PubChem), so KPV is heavier by 52.13 g/mol, a ratio of 1.18. This means 1 mg of KPV contains 2,920.3 nmol versus 3,444.7 nmol for SLU-PP-332.
How many mg of SLU-PP-332 are equimolar to 1 mg of KPV?
1 mg of KPV (MW 342.43) is 2,920.3 nmol. The same number of moles of SLU-PP-332 (MW 290.3) weighs 0.8478 mg. Equimolar comparisons matter when testing two compounds side by side in the same assay.
Compare the molecular formulas of KPV and SLU-PP-332
PubChem lists KPV as C16H30N4O4 (342.43 g/mol) and SLU-PP-332 as C18H14N2O2 (290.3 g/mol). KPV is a peptide; SLU-PP-332 is a small molecule (not a peptide). These formulas refer to the parent compounds without salt counter-ions.
A 2 mg vial of KPV equals how many mg of SLU-PP-332 in moles?
2 mg of KPV (MW 342.43) is 5.841 µmol. The same amount of SLU-PP-332 (MW 290.3) would weigh 1.696 mg. This equimolar conversion lets two compounds be compared at matched molar amounts in the same experiment.
A 5 mg vial of KPV equals how many mg of SLU-PP-332 in moles?
5 mg of KPV (MW 342.43) is 14.602 µmol. The same amount of SLU-PP-332 (MW 290.3) would weigh 4.239 mg. This equimolar conversion lets two compounds be compared at matched molar amounts in the same experiment.
A 10 mg vial of KPV equals how many mg of SLU-PP-332 in moles?
10 mg of KPV (MW 342.43) is 29.203 µmol. The same amount of SLU-PP-332 (MW 290.3) would weigh 8.478 mg. This equimolar conversion lets two compounds be compared at matched molar amounts in the same experiment.
A 20 mg vial of KPV equals how many mg of SLU-PP-332 in moles?
20 mg of KPV (MW 342.43) is 58.406 µmol. The same amount of SLU-PP-332 (MW 290.3) would weigh 16.955 mg. This equimolar conversion lets two compounds be compared at matched molar amounts in the same experiment.
A 10 mg vial of SLU-PP-332 equals how many mg of KPV in moles?
10 mg of SLU-PP-332 (MW 290.3) is 34.447 µmol. The same amount of KPV (MW 342.43) would weigh 11.796 mg. This equimolar conversion lets two compounds be compared at matched molar amounts in the same experiment.
A 5 mg vial of SLU-PP-332 equals how many mg of KPV in moles?
5 mg of SLU-PP-332 (MW 290.3) is 17.224 µmol. The same amount of KPV (MW 342.43) would weigh 5.898 mg. This equimolar conversion lets two compounds be compared at matched molar amounts in the same experiment.
A CoA for every lot; each vial carries a printed lot number that matches it. Ask with the lot number and we send it.
Cite this
Research use only. Not for consumption. No health claims.
Plain
Sable Peptides. (2026). What is the difference between KPV and SLU-PP-332?. UK Research Peptide Reference. Retrieved 11 October 2026, from https://www.sablepeptides.co.uk/questions/compare/kpv-vs-slu-pp-332/#sqa-039660
APA
Sable Peptides. (2026, October 11). *What is the difference between KPV and SLU-PP-332?*. UK Research Peptide Reference. https://www.sablepeptides.co.uk/questions/compare/kpv-vs-slu-pp-332/#sqa-039660
BibTeX
@misc{sable_#sqa-039660_2026,
author = {{Sable Peptides}},
title = {{What is the difference between KPV and SLU-PP-332?}},
year = {2026},
howpublished = {\url{https://www.sablepeptides.co.uk/questions/compare/kpv-vs-slu-pp-332/#sqa-039660}},
note = {Accessed 11 October 2026. CC BY 4.0}
}Badge
<a href="https://www.sablepeptides.co.uk/ref"><img src="https://www.sablepeptides.co.uk/badge/ref.svg" alt="Data: UK Research Peptide Reference — Sable Peptides" width="220" height="40"></a>
Date modified: 2026-10-10